Nav: Home

Notorious cancer protein mutations cooperate to proliferate disease

May 18, 2020

Understanding the genetic mutations and protein changes that take place in the progression of cancer is key to its treatment. Mutations in the gene TP53 and concomitant mutant p53 proteins in cancer cells have become notorious over the course of multiple studies of several different types of cancers. Yet so far, the mechanisms behind the role of these protein changes in propagating the disease has been poorly understood. Masanobu Oshima at Kanazawa University and his collaborators now report results that suggest just how these protein changes may lead to accelerated tumorigenesis and metastasis.

Previous studies of cancers in the lungs, intestines and pancreas, as well as colorectal cancer, had suggested that changes in p53 lead to invasive abilities and stem cell characteristics crucial for late-stage tumorigenesis. In addition to this "gain of function (GOF)" mutation, wild-type protein p53 is reduced in cancer cells through a "loss of heterozygosity" process, where instead of having two alleles for each gene corresponding to each parent, the gene has just one.

Oshima collaborated with researchers at Kanazawa University in Japan, Theragen Etex Bio Institute and Seoul National University in South Korea. They found that tumor cells that carry GOF mutant p53 and lost wild-type p53 are enriched in liver metastasis lesions, suggesting combination of p53 LOH and GOF mutations promotes metastasis (Fig. 1). In studies of single cells dissociated from each other, the researchers found that loss of heterozygosity was key to the cell's survival and proliferation, which has implications for metastasis. In addition, the structures formed were more complex and glandular.

Further studies suggested that the combination of gain of function mutations and loss of heterozygosity provided some protection against cell death. When injected in live mouse models the combination also accelerated tumorigenesis as well. The tumours formed had a fibrotic microenvironment, a signature of a poor prognosis for colorectal cancer.

Fibrotic structures are also linked with inflammation pathways. The researchers analysed the mutant proteins with the ingenuity pathway analysis software package, which provides integrated analysis of gene expression and other cell traits. The analysis indicated growth factor/MAPK and inflammatory pathways were indeed upregulated in cells with gain of function mutations and loss of heterozygosity. What is more trametinib treatment, (which inhibits a protein in the MAPK pathway) suppressed the cloning efficiency of these mutant cells. Ingenuity pathway analysis also revealed that stem cell pathways were up regulated in cells with gain of function mutations and loss of heterozygosity, as well as cells where both Trp53 alleles were disrupted (Fig. 2). In their report, the researchers suggest their findings "will contribute to the future development of therapeutic strategies against CRC [colorectal cancer] metastasis."
-end-
[Background]

Colorectal cancer


Colorectal cancer is one of the most fatal cancers world-wide. Not only are TP53 genetic mutations found in 55-60% of colorectal cancers but the percentage rises to 80% in metastasis-related cases of colorectal cancer, implying it has a role in the malignant progression of the cancer.

Tumorigenesis

In tumour initiation healthy cells become cancerous - their genetic make-up mutates and abnormal cell division processes take over. In healthy cells, proliferation and apoptosis (programmed cell death) balance. The imbalance between these processes is thought to be key to the onset and proliferation of cancer.

The researchers' studies of the cells with respect to a process that causes intestinal epithelial cell death - anoikis - revealed that the combination of gain of function mutations and loss of heterozygosity provided cells with a level of protection. This could knock out of kilter the balance of production and destruction of cells - so delicately tuned in healthy cells.

Metastasis

Metastasis describes the spread of cancer to different parts of the body often through the lymph system or bloodstream. Tumours then develop at new sites from just a handful of cells. The study of how cells that had gain of function mutations in the p53 protein fared once dissociated from each other has implications for metastasis. In fact the researchers found little difference between cells with or without loss of heterozygosity when they mechanically dissociated them. Here the dissociated cells remain as tumour glands rather than single cells. The real difference was observed when they used enzymes to dissociate them into single cells, and the single cells were subcloned (a technique for moving DNA into daughter cells). The subcloned population lost their wild-type Trp53, even when subcloned from cells with heterozygous Trp53 gain of function mutations.

Kanazawa University

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.